Clinical Trial Update: Alemtuzumab in Treating Patients With Advanced Chronic Lymphocytic Leukemia That Did Not Respond to Previous Fludarabine [Phase 2]

View source ↗

Summary

Phase 2 trial update for alemtuzumab in advanced chronic lymphocytic leukemia that did not respond to prior fludarabine reports the study status as completed. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Alemtuzumab (Alemtuzumab)

Snippet

Sponsor: German CLL Study Group | Conditions: Leukemia | Phase 2 | Status: COMPLETED